ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 162 filers reported holding ACORDA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 2.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $8,000 | +33.3% | 11,315 | 0.0% | 0.00% | – |
Q3 2020 | $6,000 | -60.0% | 11,315 | -46.9% | 0.00% | – |
Q2 2020 | $15,000 | -25.0% | 21,315 | 0.0% | 0.00% | -100.0% |
Q1 2020 | $20,000 | -94.4% | 21,315 | -87.7% | 0.00% | -90.0% |
Q4 2019 | $354,000 | +45.7% | 173,415 | +104.5% | 0.02% | +25.0% |
Q3 2019 | $243,000 | +215.6% | 84,800 | +748.0% | 0.02% | +300.0% |
Q2 2019 | $77,000 | -42.1% | 10,000 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $133,000 | -54.9% | 10,000 | -33.3% | 0.01% | -38.5% |
Q3 2018 | $295,000 | -46.9% | 15,000 | -22.7% | 0.01% | -50.0% |
Q2 2018 | $556,000 | -68.3% | 19,400 | -73.9% | 0.03% | -70.1% |
Q1 2018 | $1,756,000 | +105.1% | 74,300 | +85.8% | 0.09% | +107.1% |
Q4 2017 | $856,000 | +81.4% | 40,000 | +100.0% | 0.04% | +82.6% |
Q3 2017 | $472,000 | +700.0% | 20,000 | +566.7% | 0.02% | +666.7% |
Q2 2017 | $59,000 | +25.5% | 3,000 | +20.0% | 0.00% | 0.0% |
Q4 2016 | $47,000 | -28.8% | 2,500 | 0.0% | 0.00% | -25.0% |
Q3 2015 | $66,000 | – | 2,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 325,000 | $8,289,000 | 2.39% |
ARMISTICE CAPITAL, LLC | 232,000 | $5,917,000 | 2.25% |
SENZAR ASSET MANAGEMENT, LLC | 358,191 | $9,135,662,000 | 1.99% |
SCOPIA CAPITAL MANAGEMENT LP | 3,171,229 | $80,882,000 | 1.67% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,029,410 | $26,255,000 | 1.03% |
Baker Brothers Advisors | 3,661,082 | $93,376,000 | 0.98% |
ARBOR CAPITAL MANAGEMENT LLC | 58,783 | $1,499,000 | 0.79% |
Spark Investment Management LLC | 292,400 | $7,457,000 | 0.70% |
SPHERA FUNDS MANAGEMENT LTD. | 98,000 | $2,499,000 | 0.65% |
Virtus ETF Advisers LLC | 21,130 | $539,000 | 0.40% |